Skip to content

BBNX BBNX Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering

Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering at other companies

Regenxbio logo
RegenxbioRGNX
$124.75K-20.5%
XOMA Corporation logo
XOMA CorporationXOMA
$144.5K
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$149.75K
Community Healthcare Trust logo
Community Healthcare TrustCHCT
$43K+13.2%
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$0-100%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept bbnx:ReclassificationOfDeferredOfferingCostsToEquityUponInitialPublicOffering.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's reclassification of deferred offering costs to equity upon initial public offering.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's reclassification of deferred offering costs to equity upon initial public offering?
BBNX (BBNX) reported reclassification of deferred offering costs to equity upon initial public offering of $5.05M in Q1 2025.
What does reclassification of deferred offering costs to equity upon initial public offering mean?
This metric represents the non-cash reclassification of capitalized costs associated with an initial public offering from the balance sheet directly into equity upon the successful completion of the offering. It reflects the final accounting treatment of expenses incurred to facilitate the company's transition to a publicly traded entity. Investors monitor this to understand the impact of IPO-related issuance costs on the company's total equity base.